Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer in the development of the country's first indigenous Cell & Gene Therapy. With a rapidly expanding pipeline beginning with blood cancers, our mission is to provide affordable access to novel autologous CAR-T cell therapies.

Therapeutics

Life Sciences

Biotechnology

ImmunoACT

ImmunoACT's headquarters in Navi Mumbai, India

Rahul Purwar

Dr. Brian Bernard

CA RAJAT MAHESHWARI

Amritansh F.

Shalini Purwar

Anita Samagod

This department ensures that products meet quality standards through systematic testing and analysis.

Quality Assurance

This department conducts scientific research and experimentation to drive innovation and development.

Research Division

The Scientific Research Team at ImmunoACT focuses on advancing the development of innovative cell and gene therapies, specifically targeting blood cancers. Comprising scientists at various levels, the team conducts cutting-edge research, designs experimental protocols, and analyzes data to optimize CAR-T cell therapy solutions, ultimately aiming to make these therapies accessible and affordable for patients in India.

Scientific Research Team

This department focuses on conducting scientific research and experiments to advance knowledge and innovation.

Research Science

This department provides strategic direction and oversight for the organization.

Executive Leadership

This department manages and supports the execution of clinical trials to ensure compliance and efficient data collection.

ImmunoACT

Org chart

Teams

Quality Assurance

Research Division

Scientific Research Team

Research Science

Executive Leadership

Clinical Trials

Offices

ImmunoACT

Org chart

Teams

Quality Assurance

Research Division

Scientific Research Team

Research Science

Executive Leadership

Clinical Trials

Offices

Related companies